Literature DB >> 17237758

Cardiac-specific overexpression of E40K active Akt prevents pressure overload-induced heart failure in mice by increasing angiogenesis and reducing apoptosis.

M Ceci, P Gallo, M Santonastasi, S Grimaldi, M V G Latronico, A Pitisci, E Missol-Kolka, M C Scimia, D Catalucci, D Hilfiker-Kleiner, G Condorelli.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17237758     DOI: 10.1038/sj.cdd.4402095

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


× No keyword cloud information.
  16 in total

1.  MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice.

Authors:  Denghong Zhang; Riccardo Contu; Michael V G Latronico; Jianlin Zhang; Jian Ling Zhang; Roberto Rizzi; Daniele Catalucci; Shigeki Miyamoto; Katherine Huang; Marcello Ceci; Yusu Gu; Nancy D Dalton; Kirk L Peterson; Kun-Liang Guan; Joan Heller Brown; Ju Chen; Nahum Sonenberg; Gianluigi Condorelli
Journal:  J Clin Invest       Date:  2010-07-19       Impact factor: 14.808

2.  H-Ras Isoform Mediates Protection Against Pressure Overload-Induced Cardiac Dysfunction in Part Through Activation of AKT.

Authors:  Takahisa Matsuda; Jae Im Jeong; Shohei Ikeda; Takanobu Yamamoto; Shumin Gao; Gopal J Babu; Peiyong Zhai; Dominic P Del Re
Journal:  Circ Heart Fail       Date:  2017-02       Impact factor: 8.790

Review 3.  Myocardial AKT: the omnipresent nexus.

Authors:  Mark A Sussman; Mirko Völkers; Kimberlee Fischer; Brandi Bailey; Christopher T Cottage; Shabana Din; Natalie Gude; Daniele Avitabile; Roberto Alvarez; Balaji Sundararaman; Pearl Quijada; Matt Mason; Mathias H Konstandin; Amy Malhowski; Zhaokang Cheng; Mohsin Khan; Michael McGregor
Journal:  Physiol Rev       Date:  2011-07       Impact factor: 37.312

4.  DDiT4L promotes autophagy and inhibits pathological cardiac hypertrophy in response to stress.

Authors:  Bridget Simonson; Vinita Subramanya; Mun Chun Chan; Aifeng Zhang; Hannabeth Franchino; Filomena Ottaviano; Manoj K Mishra; Ashley C Knight; Danielle Hunt; Ionita Ghiran; Tejvir S Khurana; Maria I Kontaridis; Anthony Rosenzweig; Saumya Das
Journal:  Sci Signal       Date:  2017-02-28       Impact factor: 8.192

5.  Akt and MAPK signaling mediate pregnancy-induced cardiac adaptation.

Authors:  Eunhee Chung; Fan Yeung; Leslie A Leinwand
Journal:  J Appl Physiol (1985)       Date:  2012-02-16

6.  Distinctive ERK and p38 signaling in remote and infarcted myocardium during post-MI remodeling in the mouse.

Authors:  Che-Chung Yeh; Hongzhe Li; Deepak Malhotra; Sally Turcato; Susan Nicholas; Richard Tu; Bo-Qing Zhu; John Cha; Philip M Swigart; Bat-Erdene Myagmar; Anthony J Baker; Paul C Simpson; Michael J Mann
Journal:  J Cell Biochem       Date:  2010-04-15       Impact factor: 4.429

7.  Physiological activation of Akt by PHLPP1 deletion protects against pathological hypertrophy.

Authors:  Courtney Moc; Amy E Taylor; Gino P Chesini; Cristina M Zambrano; Melissa S Barlow; Xiaoxue Zhang; Åsa B Gustafsson; Nicole H Purcell
Journal:  Cardiovasc Res       Date:  2014-11-19       Impact factor: 10.787

Review 8.  Akt mediated mitochondrial protection in the heart: metabolic and survival pathways to the rescue.

Authors:  Shigeki Miyamoto; Anne N Murphy; Joan Heller Brown
Journal:  J Bioenerg Biomembr       Date:  2009-04       Impact factor: 2.945

9.  Cardiac Stim1 Silencing Impairs Adaptive Hypertrophy and Promotes Heart Failure Through Inactivation of mTORC2/Akt Signaling.

Authors:  Ludovic Bénard; Jae Gyun Oh; Marine Cacheux; Ahyoung Lee; Mathieu Nonnenmacher; Daniel S Matasic; Erik Kohlbrenner; Changwon Kho; Catherine Pavoine; Roger J Hajjar; Jean-Sébastien Hulot
Journal:  Circulation       Date:  2016-03-02       Impact factor: 29.690

10.  TASK-1 and TASK-3 channels modulate pressure overload-induced cardiac remodeling and dysfunction.

Authors:  Wei Duan; Jonné Hicks; Michael A Makara; Olga Ilkayeva; Dennis M Abraham
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-01-24       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.